Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples

@inproceedings{Dheda2010ClinicalUO,
  title={Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples},
  author={Keertan Dheda and Virginia Davids and Laura Lenders and Teri Roberts and Richard Meldau and Daphne I. Ling and Laurence Brunet and Richard van Zyl Smit and Jonathan Peter and Clare Green and Motasim Badri and Leonardo A Sechi and Surendra Sharma and Michael Hoelscher and Rodney Dawson and Andrew Whitelaw and Jonathan Blackburn and Madhukar Pai and Alimuddin M. Zumla},
  booktitle={PloS one},
  year={2010}
}
BACKGROUND The accurate diagnosis of TB in HIV-infected patients, particularly with advanced immunosuppression, is difficult. Recent studies indicate that a lipoarabinomannan (LAM) assay (Clearview-TB(R)-ELISA) may have some utility for the diagnosis of TB in HIV-infected patients; however, the precise subgroup that may benefit from this technology requires… CONTINUE READING